作者: Scott E. Schaus , Joshua A. Bishop , Ulla Hansen
DOI:
关键词:
摘要: The present invention relates generally to [l,3]dioxolo[4,5-g]quinoline-6(5H)thione and [1,3]dioxolo[4,5-g][1,2,4]triazolo[1,5-a]quinoline derivatives and/or compositions for use in inhibiting, preventing treating cancer, e.g. hepatocellular carcionoma (HCC). In some embodiments, the of small-molecule compounds inhibit, prevent treat expression transcription factor Late SV40 Factor (LSF) treatment HCC or other cancer types.